PureTech Health plc (PRTC.L)
GBp 164.0
(2.5%)
GBp 164.0
(2.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -132.31 Million USD | 34.73% |
| 2022 | -79.93 Million USD | 5.67% |
| 2021 | -46.95 Million USD | -48.45% |
| 2020 | -144.75 Million USD | -52.62% |
| 2019 | -94.85 Million USD | 23.46% |
| 2018 | -65.26 Million USD | 10.63% |
| 2017 | -67.9 Million USD | -79.19% |
| 2016 | -77.38 Million USD | -70.54% |
| 2015 | -54.74 Million USD | -167.82% |
| 2014 | -73.17 Million USD | -552.7% |
| 2013 | -4.49 Million USD | 52.92% |
| 2012 | -9.67 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -32.29 Million USD | 0.0% |
| 2024 Q1 | -32.29 Million USD | 5.8% |
| 2023 Q3 | -34.01 Million USD | 6.93% |
| 2023 Q4 | -34.28 Million USD | -0.78% |
| 2023 Q1 | -36.55 Million USD | 23.1% |
| 2023 Q2 | -36.55 Million USD | 0.0% |
| 2023 FY | - USD | 34.73% |
| 2022 Q1 | -48.44 Million USD | -20.2% |
| 2022 FY | - USD | 5.67% |
| 2022 Q4 | -47.53 Million USD | 0.0% |
| 2022 Q3 | -47.53 Million USD | 1.89% |
| 2022 Q2 | -48.44 Million USD | 0.0% |
| 2021 Q2 | -32.65 Million USD | 0.0% |
| 2021 FY | - USD | -48.45% |
| 2021 Q4 | -40.3 Million USD | 0.0% |
| 2021 Q3 | -40.3 Million USD | -23.41% |
| 2021 Q1 | -32.65 Million USD | -0.87% |
| 2020 Q1 | -25.41 Million USD | 19.49% |
| 2020 FY | - USD | -52.62% |
| 2020 Q2 | -25.41 Million USD | 0.0% |
| 2020 Q3 | -32.37 Million USD | -27.41% |
| 2020 Q4 | -32.37 Million USD | 0.0% |
| 2019 Q1 | -34.46 Million USD | -38.11% |
| 2019 Q3 | -31.56 Million USD | 8.4% |
| 2019 Q4 | -31.56 Million USD | 0.0% |
| 2019 Q2 | -34.46 Million USD | 0.0% |
| 2019 FY | - USD | 23.46% |
| 2018 Q4 | -24.95 Million USD | 0.0% |
| 2018 FY | - USD | 10.63% |
| 2018 Q3 | -24.95 Million USD | 2.8% |
| 2018 Q2 | -25.66 Million USD | 0.0% |
| 2018 Q1 | -25.66 Million USD | 10.15% |
| 2017 Q3 | -28.56 Million USD | -2.86% |
| 2017 FY | - USD | -79.19% |
| 2017 Q2 | -27.77 Million USD | 0.0% |
| 2017 Q1 | -27.77 Million USD | -44.29% |
| 2017 Q4 | -28.56 Million USD | 0.0% |
| 2016 Q4 | -19.24 Million USD | 0.0% |
| 2016 FY | - USD | -70.54% |
| 2016 Q2 | -16.93 Million USD | 0.0% |
| 2016 Q1 | -16.93 Million USD | -7.23% |
| 2016 Q3 | -19.24 Million USD | -13.69% |
| 2015 Q3 | -15.78 Million USD | -178.89% |
| 2015 Q2 | -5.66 Million USD | 0.0% |
| 2015 Q1 | -5.66 Million USD | 7.9% |
| 2015 FY | - USD | -167.82% |
| 2015 Q4 | -15.78 Million USD | 0.0% |
| 2014 Q2 | -2.34 Million USD | 0.0% |
| 2014 Q1 | -2.34 Million USD | 75.84% |
| 2014 FY | - USD | -552.7% |
| 2014 Q4 | -6.14 Million USD | 0.0% |
| 2014 Q3 | -6.14 Million USD | -161.8% |
| 2013 FY | - USD | 52.92% |
| 2013 Q1 | -802.25 Thousand USD | 0.0% |
| 2013 Q3 | -802.25 Thousand USD | 0.0% |
| 2013 Q2 | -802.25 Thousand USD | 0.0% |
| 2013 Q4 | -9.71 Million USD | -1111.34% |
| 2012 Q3 | -2.35 Million USD | 0.0% |
| 2012 Q2 | -2.35 Million USD | 0.0% |
| 2012 Q1 | -2.35 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -802.25 Thousand USD | 65.9% |
| 2011 Q4 | -2.35 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|